基蛋生物 (603387)
Getein Biotech, Inc.
K-Line Chart
No K-line data available
Company NameGetein Biotech, Inc.
Listing Date2017-07-17
Issue Price22.25RMB
Registered Capital50715.351710k RMB
Legal RepresentativeEnben Su
Registered AddressNo. 9 Bofu Road, Yanjiang Industrial Development Zone, Liuhe District, Nanjing City, Jiangsu Province, China
IndustryMedical Devices
Main BusinessPrimarily engaged in the research and development, production, and sales of in vitro diagnostic products.
Company ProfileGetein Biotech, Inc. (Stock Code: 603387) was founded in 2002. It is a comprehensive healthcare industry chain company integrating independent R&D, large-scale production, and professional marketing, with numerous subsidiaries and offices both domestically and internationally. The company was listed on the Main Board of the Shanghai Stock Exchange in July 2017, making it one of the Main Board listed enterprises in the POCT field in China.
The company consistently focuses on the R&D, production, sales, and service of in vitro diagnostic (IVD) products. It possesses a professional diagnostic product R&D team and has successively established five major technology platforms: colloidal gold immunochromatography, fluorescence immunochromatography, biochemistry, chemiluminescence, and diagnostic raw materials. The company has extensive market management experience and channel management capabilities, providing comprehensive professional services to product distributors and end customers. In recent years, the company has developed rapidly, establishing a comprehensive marketing network with over 20 subsidiaries and offices across the country. It actively explores the international market, with products successfully sold to over 100 countries and regions in Europe, the Americas, Asia, and Africa. The company's operating revenue has grown rapidly, and its output value and sales volume rank among the top in domestic peer enterprises.
Stock Details
1. Key Indicators
- Total Shares(W): 50715.35
- Circulating A-Shares(W): 50715.35
- Earnings Per Share(RMB): 0.3200
- Net Assets Per Share(RMB): 5.3062
- Operating Revenue(W RMB): 75768.92
- Total Profit(W RMB): 16317.53
- **Net Profit Attributable to Parent(W RMB) **: 16054.38
- Net Profit Growth Rate(%): -8.48
- Weighted Return on Equity(%): 6.0000
- Operating Cash Flow Per Share(RMB): 0.4640
- Undistributed Profit Per Share(RMB): 3.3303
- Capital Reserve Per Share(RMB): 0.4656
2. Main Business
The main business covers:
- Research, development, production, and sales of in vitro diagnostic products.
3. Company Basic Information
- Company Name: Getein Biotech, Inc.
- Listing Date: 2017-07-17
- Industry: Pharmaceutical Manufacturing
- Address: No. 9 Bofu Road, Yanjiang Industrial Development Zone, Luhe District, Nanjing City, Jiangsu Province
- Website: https://www.getein.com.cn/
- Company Profile: The issuer was established as a joint stock company through the overall change of Getein Limited. Getein Limited converted its audited net assets as of September 30, 2014, into the company's share capital of 99 million shares at RMB 1 per share, with the remaining portion of the audited net assets recorded into the company's capital reserve. The shareholding ratios of all shareholders remained unchanged before and after the issuer's transformation into a joint stock company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Nanjing Aiji Business Information Consulting Co., Ltd. | General Legal Person | 1688.12 | 3.33 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1287.25 | 2.54 |
5. Concept Sectors
- Venture Capital Concept
- Helicobacter Pylori Concept
- Hepatitis Concept
- Pet Economy
- Margin Trading & Securities Lending
Remarks
- Data update date: 2025-11-01
- Data source: Public Market Information